Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has informed that it enclosed a copy of the Press Release about Sun Pharma signing a non-exclusive patent licensing agreement with Takeda for introducing Novel Gastrointestinal Drug, Voltapraz (Vonoprazan) in India, which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.